Literature DB >> 10533192

Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology.

T Inoue1, N Oriuchi, M Kunio, K Tomiyoshi, Y Tomaru, K Aoyagi, S Amano, H Suzuki, J Aoki, T Sato, K Endo.   

Abstract

We assessed the accuracy of the standardized uptake value (SUV) measured by simultaneous emission and transmission scanning in cancer patients using FDG positron emission tomography (PET). Conventional, independent emission (E)/transmission (T) scans and simultaneous E/T scans were conducted consecutively in 30 patients who underwent FDG PET examinations. The SUVs of 35 mass lesions and 34 selected normal tissues were derived from the independent E/T scan and simultaneous E/T scan. Experimental studies using a cylindrical phantom were also conducted to evaluate the accuracy and reproducibility of the SUV derived from a simultaneous E/T scan. The SUVs of 18F solution in the phantom were estimated to be approximately 1, with high reproducibility in the range of total counts observed in the clinical examinations. There were no significant differences in the SUVs in 35 tumours derived from simultaneous E/T scans and those derived from independent scans, and there was a strong positive correlation between the two (r = 0.99, P < 0.01). There were also no significant differences in the SUVs in 34 normal tissue regions derived from simultaneous E/T scans and those derived from independent scans. In conclusion, simultaneous E/T scanning with FDG in patients with malignant tumours is a valid method, since the SUV derived from the simultaneous scan is accurate and reproducible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533192     DOI: 10.1097/00006231-199909000-00012

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  7 in total

1.  Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.

Authors:  Yasushi Domeki; Erena Yamazaki; Akira Matsuura; Kazuhiro Kitajima; Koji Murakami; Hiroyuki Kato
Journal:  Surg Today       Date:  2012-07-24       Impact factor: 2.549

2.  18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.

Authors:  Yoichi Kamiyama; Ryuusuke Aihara; Toshihiro Nakabayashi; Erito Mochiki; Takayuki Asao; Hiroyuki Kuwano; Nobuo Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

3.  Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.

Authors:  Tsutomu Namikawa; Takehiro Okabayshi; Munenobu Nogami; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Int J Clin Oncol       Date:  2013-07-24       Impact factor: 3.402

4.  Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.

Authors:  Manabu Tashiro; Xudong Duan; Motohisa Kato; Masayasu Miyake; Shoichi Watanuki; Yoichi Ishikawa; Yoshihito Funaki; Ren Iwata; Masatoshi Itoh; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

5.  The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.

Authors:  Tsuyoshi Kawano; Akiko Suzuki; Amane Ishida; Nobukazu Takahashi; Jin Lee; Yoshifumi Tayama; Takashi Oka; Shumpei Yokota; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-13       Impact factor: 9.236

6.  Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.

Authors:  Erito Mochiki; Hiroyuki Kuwano; Hiroyuki Katoh; Takayuki Asao; Noboru Oriuchi; Keigo Endo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

7.  Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.

Authors:  S Suzuki; K Kaira; Y Ohshima; N S Ishioka; M Sohda; T Yokobori; T Miyazaki; N Oriuchi; H Tominaga; Y Kanai; N Tsukamoto; T Asao; Y Tsushima; T Higuchi; T Oyama; H Kuwano
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.